Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for treating rheumatoid arthritis

A rheumatoid, composition technology, applied in the directions of drug combinations, antipyretics, anti-inflammatory agents, etc., can solve the problems of slow analgesic and anti-inflammatory effects, long medication time, poor repeatability, etc., and achieve good therapeutic effect and effective. High composition and targeted effect

Inactive Publication Date: 2014-05-28
支得福
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The current traditional Chinese medicine treatment of rheumatoid arthritis usually has the disadvantages of long medication time, slow analgesic and anti-inflammatory effects, poor repeatability, and difficult to cure.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating rheumatoid arthritis
  • Medicinal composition for treating rheumatoid arthritis
  • Medicinal composition for treating rheumatoid arthritis

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0023] Experimental Example 1 Clinical comparative experiment on the treatment of rheumatoid arthritis by the pharmaceutical composition of the present invention

[0024] Treatment group: oral administration of the pharmaceutical composition capsule preparation of the present invention (made in Example 1) for three treatment courses (9 days a treatment course), 3 times a day, 2 capsules each time; control group: oral administration for general treatment of rheumatoid arthritis Medicine (indomethacin tablets, specification: 25 mg tablets) for three courses, 1 tablet each time, 3 times a day, taken after meals. Through clinical comparison, the results are shown in Table 1.

[0025] The curative effect standard is drawn up as follows with reference to the "Diagnosis and Curative Effect Standards for Chinese Medicine Diseases" implemented by the State Administration of Traditional Chinese Medicine in 1994:

[0026] Clinical recovery: The clinical symptoms and signs of traditional Chines...

experiment example 2

[0033] Experimental Example 2 Experiment of the pharmaceutical composition of the present invention to relieve elbow joint swelling and pain

[0034] Sun, 30 years old, female, suffering from rheumatoid arthritis for 3 years. Symptoms: The patient's elbow joints are swollen without deformation, the joints feel stiff and tight in the morning, and the joints are not flexed and extended.

[0035] By taking the pharmaceutical composition capsule preparation of the present invention (made in Example 1) for one course of treatment, the swelling of both elbow joints disappeared, and the joint pain was significantly improved. After four courses of continued treatment, the examination has basically returned to normal.

experiment example 3

[0036] Experimental example 3 The experiment of the pharmaceutical composition of the present invention to relieve joint swelling and pain

[0037] Zhang, female, 55 years old. Symptoms: The patient’s left leg ankle joint, pain and swelling, walking inconvenience, aggravated due to labor, was diagnosed as rheumatism.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicinal composition for treating rheumatoid arthritis. The medicinal composition is prepared from monkshood, orientvine, astragalus root, processed radix aconiti, scorpion, rhizome of large-headed atractylodes, white grub, yam rhizome, liquoric root, arisacma consanguineum and pinellia tuber. The conventional auxiliary materials are added into the raw material medicines to prepare the clinically acceptable various formulations, such as capsules, granules, tablets and oral liquid preparation, according to the conventional process. The invention also provides application of the medicinal composition preparation to preparation of medicaments for treating the rheumatoid arthritis and various pains and edema caused by rheumatism.

Description

Technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a medicine composition for treating rheumatoid arthritis, various pains and edema caused by rheumatoid arthritis. Background technique [0002] Rheumatoid, Chinese medicine believes that it belongs to the category of arthralgia in traditional Chinese medicine. Due to insufficient righteousness, liver and kidney deficiency, and insufficient righteousness are the internal causes of the disease and play a decisive role. When the righteous qi is insufficient, the external wind, cold, damp and heat can take advantage of the deficiency to invade the limbs, joints and muscles, blocking the meridians and causing arthralgia. "Lingshu·All Diseases Begin to Reproduce" pointed out that "Wind, rain, cold and heat cannot be empty, evil cannot alone injure people, and those who do not get sick in sudden storms and rains will cover the vitality. Therefore evil cannot alone injure people."...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8888A61P19/02A61P29/00A61K35/64A61K35/646
Inventor 支得福
Owner 支得福
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com